Norman L. Wright Acquires 3,411 Shares of Option Care Health (NASDAQ:OPCH) Stock

Key Points

• Option Care Health Director Norman Wright purchased $99,976.41 worth of stock, acquiring 3,411 shares at an average price of $29.31 each, increasing his position by 28.21% to a total of 15,501 shares.
• The company reported a 15.4% revenue growth year-over-year, with earnings per share of $0.41 for the last quarter, surpassing analyst expectations.
• Analysts remain optimistic, with eight analysts rating the stock as a Buy and a consensus target price of $35.75, signaling confidence in Option Care Health's future performance.

Option Care Health, Inc. (NASDAQ:OPCH - Get Free Report) Director Norman L. Wright purchased 3,411 shares of the business's stock in a transaction that occurred on Tuesday, September 9th. The stock was acquired at an average price of $29.31 per share, with a total value of $99,976.41. Following the purchase, the director owned 15,501 shares in the company, valued at $454,334.31. This represents a 28.21% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

Option Care Health Price Performance

Shares of Option Care Health stock traded down $0.59 on Monday, hitting $27.89. The company's stock had a trading volume of 1,351,279 shares, compared to its average volume of 1,864,932. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.00 and a current ratio of 1.52. Option Care Health, Inc. has a 1 year low of $21.39 and a 1 year high of $35.53. The firm has a fifty day moving average price of $29.09 and a 200-day moving average price of $31.42. The company has a market capitalization of $4.53 billion, a price-to-earnings ratio of 19.78, a price-to-earnings-growth ratio of 1.73 and a beta of 0.83.

Option Care Health (NASDAQ:OPCH - Get Free Report) last announced its quarterly earnings results on Wednesday, July 30th. The company reported $0.41 earnings per share for the quarter, beating the consensus estimate of $0.40 by $0.01. Option Care Health had a return on equity of 17.53% and a net margin of 3.93%.The firm had revenue of $1.42 billion during the quarter, compared to analyst estimates of $1.35 billion. During the same quarter in the previous year, the business earned $0.30 EPS. Option Care Health's revenue for the quarter was up 15.4% compared to the same quarter last year. Option Care Health has set its FY 2025 guidance at 1.650-1.720 EPS. As a group, sell-side analysts anticipate that Option Care Health, Inc. will post 1.22 earnings per share for the current fiscal year.

Institutional Trading of Option Care Health

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. USA Financial Formulas purchased a new stake in Option Care Health in the second quarter valued at approximately $26,000. Northwestern Mutual Wealth Management Co. increased its position in shares of Option Care Health by 1,492.9% during the first quarter. Northwestern Mutual Wealth Management Co. now owns 892 shares of the company's stock worth $31,000 after acquiring an additional 836 shares during the period. McIlrath & Eck LLC purchased a new stake in shares of Option Care Health during the second quarter worth $37,000. Brooklyn Investment Group increased its position in shares of Option Care Health by 186.6% during the first quarter. Brooklyn Investment Group now owns 1,198 shares of the company's stock worth $42,000 after acquiring an additional 780 shares during the period. Finally, Elevation Point Wealth Partners LLC purchased a new stake in shares of Option Care Health during the second quarter worth $40,000. Hedge funds and other institutional investors own 98.05% of the company's stock.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on OPCH shares. Citigroup reiterated an "outperform" rating on shares of Option Care Health in a report on Thursday, July 31st. Barrington Research reiterated an "outperform" rating and issued a $38.00 price objective on shares of Option Care Health in a report on Thursday, July 10th. Finally, JMP Securities lifted their price objective on Option Care Health from $36.00 to $38.00 and gave the stock a "market outperform" rating in a report on Thursday, July 31st. Eight investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. According to MarketBeat.com, Option Care Health presently has an average rating of "Moderate Buy" and an average target price of $35.75.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.